ScienceOpen:
research and publishing network
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
My ScienceOpen
Sign in
Register
Dashboard
Blog
About
Search
Advanced search
My ScienceOpen
Sign in
Register
Dashboard
Search
Search
Advanced search
For Publishers
Discovery
Metadata
Peer review
Hosting
Publishing
For Researchers
Join
Publish
Review
Collect
Blog
About
2
views
0
references
Top references
cited by
4
0 reviews
Review
0
comments
Comment
0
recommends
+1
Recommend
0
collections
Add to
0
shares
Share
Twitter
Sina Weibo
Facebook
Email
1,665
similar
All similar
Record
: found
Abstract
: not found
Article
: not found
Antibody responses to the BBV152 vaccine in individuals previously infected with SARS-CoV-2: A pilot study
Author(s):
NP Kumar
,
C Padmapriyadarsini
,
KRU Devi
,
VV Banurekha
,
A Nancy
,
S Mandal
,
T BHATNAGAR
,
N. Arinaminpathy
,
A. Agarwal
,
A. Chowdhury
,
I.J.M. Res
,
F Wu
,
Odame
,
H Monica
,
Y Días
,
M PAI
,
M. RAVIGLIONE
Publication date:
2021
Journal:
Indian J Med Res
Read this article at
ScienceOpen
Publisher
PubMed
Bookmark
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Related collections
Malaria vaccine development
Author and article information
Journal
DOI::
10.4103/ijmr.ijmr
PubMed ID::
29923507
ScienceOpen disciplines:
Immunology
Data availability:
ScienceOpen disciplines:
Immunology
Comments
Comment on this article
Sign in to comment
scite_
Similar content
1,665
Neutralization of Beta and Delta variant with sera of COVID-19 recovered cases and vaccinees of inactivated COVID-19 vaccine BBV152/Covaxin2
Authors:
PD Yadav
Factors associated with the decay of anti-SARS-CoV-2 S1 IgG antibodies among recipients of an adenoviral vector-based AZD1222 and a whole-virion inactivated BBV152 vaccine
Authors:
S.T. Selvavinayagam
,
Y.K. Yong
,
H.Y. Tan
…
Efficacy, safety, and lot to lot immunogenicity of an inactivated SARS‐CoV‐2 vaccine 1 (BBV152): a, double‐blind, randomised, controlled phase 3 trial
Authors:
Ella R
,
Ella
See all similar
Cited by
3
Inactivated vaccine Covaxin/BBV152: A systematic review
Authors:
Tousief Irshad Ahmed
,
Saqib Rishi
,
Summaiya Irshad
…
Distribution of Antibiotic-Resistant Enterobacteriaceae Pathogens in Potable Spring Water of Eastern Indian Himalayas: Emphasis on Virulence Gene and Antibiotic Resistance Genes in Escherichia coli
Authors:
Ashish Singh
,
Saurav Das
,
Santosh Dubey Kumar
…
Study and impact analysis of COVID-19 pandemic clinical data on infection spreading
Authors:
Sasmita Parida
,
Aisworya Mohanty
,
Suvendu Nayak
…
See all cited by